This month, we’re clearing the air around integrase inhibitors. They are by far the world’s most commonly prescribed HIV drug class -- but that ubiquity has come with long-standing concerns around their potential to cause a range of adverse events, from weight gain to birth defects and more. Our executive editor Myles Helfand speaks with Laura Waters, M.D., FRCP, the head of the British HIV Association, about what the available science tells us.     Read the transcript: https://www.thebodypro.com/article/future-hiv-care-podcast-integrase-inhibitors-laura-waters      Credits: Our executive producer is Myles Helfand; our project manager is Alina Mogollon-Volk; our audio producers/engineers are Alex Portaluppi and Lucy Mueller; and our series editors are Maria Elena Perez and Juan Michael Porter II. This episode's audio was edited by Kim Buikema.